Biota Pharmaceuticals Inc (NASDAQ:BOTA)

2.30
Data as of Aug 29
 -0.04 / -1.71%
Today’s Change
2.29
Today|||52-Week Range
7.07
-45.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$80.7M

Company Description

Biota Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening infectious diseases. The Company currently has two Phase 2 clinical-stage product candidates in development: laninamivir octanoate, a long-acting neuraminidase inhibitor that the Company is developing for the treatment of influenza A and B infections under an investigational new drug application (IND) in the United States through a contract with the U.S. Office of Biomedical Advanced Research and Development Authority (BARDA) that is designed to provide up to $231 million in financial support to complete its clinical development; and vapendavir, a potent, oral broad spectrum capsid inhibitor of enteroviruses, including human rhinovirus (HRV). In addition to these clinical-stage programs, the Company has a preclinical program focused on developing treatments for respiratory syncytial virus (RSV). Biota Pharmaceuticals was founded on November 8, 2012 and is headquartered in Alpharetta, GA.

Contact Information

Biota Pharmaceuticals, Inc.
2500 Northwinds Parkway
Alpharetta Georgia 30009
P:(678) 221-3343
Investor Relations:

Employees

Shareholders

Other institutional29.20%
Mutual fund holders12.74%
Individual stakeholders1.77%

Top Executives

Russell H. PlumbPresident, CEO, CFO, Secretary & Treasurer
John Nicholas LambertVice President-Product Development & Operations
Anna Novotney-BarryVice President-Clinical Development
Simon P. TuckerVice President-Research & Business Development
Peter J. AzzarelloChief Accounting Officer & Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.